Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study involves collecting paired tumor samples from intrasellar and cavernous sinus regions of 20 invasive pituitary tumor patients, preserving them at -80°C for quality multi-omics analysis. Proteomics and transcriptomics are employed to identify molecular differences, while imaging data (MRI/CT) assesses tumor morphology and invasion. In vitro experiments and mechanistic studies validate key findings, exploring how regional molecular differences affect tumor behavior. Data integration combines multi-omics and imaging features to uncover biomarkers and pathways associated with invasiveness and regional specificity, with statistical analysis ensuring significance and reliability.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Invasive pituitary tumors involving the cavernous sinus 2. Retrospective inclusion of patients who have signed willing to sign a consent form forms for the donation of biological samples and health-related information 3. Age range: 18-80 years 4. Subjects are willing to participate in this study Who Should NOT Join This Trial: 1. Non-invasive pituitary tumors 2. Pregnant or breastfeeding 3. Other conditions deemed unsuitable for participation in this clinical trial as assessed by the physician Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Invasive pituitary tumors involving the cavernous sinus 2. Retrospective inclusion of patients who have signed informed consent forms for the donation of biological samples and health-related information 3. Age range: 18-80 years 4. Subjects are willing to participate in this study Exclusion Criteria: 1. Non-invasive pituitary tumors 2. Pregnant or breastfeeding 3. Other conditions deemed unsuitable for participation in this clinical trial as assessed by the physician

Treatments Being Tested

OTHER

surgery

Samples were obtained from patients by surgical excision and matched into groups

Locations (1)

Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China